$XAGE Balance Sheet | Understand Stock

$XAGE

$2.32 +$0.00 (0.0%) Close

$XAGE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Accounts receivable, net
Forward purchase agreement
Assets available for sale
Other current assets
Inventory, net
Prepaid expenses
Deferred offering costs
Income taxes receivable
Accounts receivable and other current assets
Total current assets
Marketable securities held in Trust Account
Operating lease right of use asset
Property and equipment, net of accumulated depreciation of $801,887 and $775,783, respectively
Intangible assets, net of accumulated amortization of $57,924 and $55,652, respectively
Goodwill
Total assets
Current liabilities:
Accrued offering costs
Accounts payable and accrued expenses
Due to related party
Accounts payable
Accrued interest
Nonrelated Party
Related Party
Total accrued interest
Accrued expenses and other liabilities
Contingent liability
Loans payable
Nonrelated Party
Related Party
Total loans payable
Operating lease liability
Liabilities available for sale
Deferred consideration payable
Income taxes payable
Convertible notes payable
Derivative liabilities
Earnout liabilities
Consideration payable
Total current liabilities

Deferred underwriting fees payable
Long-term liabilities:
Loans payable, net of current portion
Earnout liabilities, net of current portion
Operating lease liability, net of current portion
Earnout liabilities
Deferred tax liabilities
Total liabilities
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 15,444,103 shares issued and outstanding subject to possible redemption
Common Class A
Series C-1 Redeemable Convertible Preferred Stock
Series C-2 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock
Series C-1 Redeemable Convertible Preferred Stock
Series C-2 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock

Stockholders’ deficit:
Series A convertible voting preferred stock, $0.0001 par value; 4,243 shares authorized, -0- shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Series A Convertible Preferred Stock
Total series A convertible voting preferred stock, $0.0001 par value; 4,243 shares authorized, -0- shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock, $0.0001 par value; 250,000,000 shares authorized, 2,475,321 and 1,781,738 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common Class A
Common Class B
Total common stock, $0.0001 par value; 250,000,000 shares authorized, 2,475,321 and 1,781,738 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

Additional paid-in capital
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Comments